Home
>
US Stocks
>
Alector Inc
Alector Inc
ALEC

Alector Inc

$23.3910.18%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
23.3
Today Low/High
23.13 / 23.66
52 Week Low/High
$9.12 / $43.32
Market Cap
$2.19B

Company Details

Alector is a clinical stage biotechnology company pioneering immuno-neurology, a novel therapeutic approach for the treatment of neurodegenerative diseases. The Company is developing a broad portfolio of innate immune system programs, designed to functionally repair genetic mutations that cause dysfunction of the brain's immune system and enable the rejuvenated immune cells to counteract emerging brain pathologies. Immuno-neurology targets immune dysfunction as a root cause of multiple pathologies that are drivers of degenerative brain disorders. The Company's immuno-neurology product candidates are supported by biomarkers and target genetically defined patient populations in frontotemporal dementia and Alzheimer's disease. This scientific approach is also the basis for the Company's immuno-oncology programs.
Organisation
Alector Inc
Headquaters
South San Francisco, California, US
Employees
171
Industry
Biotechnology
CEO
Arnon Rosenthal

Discover more

Frequently Asked Questions

What is Alector Inc share price today

Can Indians buy Alector Inc shares?

How can I buy Alector Inc shares from India?

Can Fractional shares of Alector Inc be purchased?

What are the documents required to start investing in Alector Inc stocks?

We are a SEBI registered investement advisor